Oct 17, 2022 | Advocacy, Featured, Research News, Technology Updates
Dexcom Announces Global Rollout of G7, as reported by Andrew Briskin for diaTribe.org, 10 October 2022. Dexcom, one of the leading manufacturers of CGM, announced on Oct. 4 that its latest product, the Dexcom G7, is now available for people with diabetes, ages 2...
Aug 15, 2022 | Advocacy, Featured, Research News, Technology Updates
Final Day: Make Your Voice Heard AGAIN to the FDA re CGM! Here’s another chance to tell them, in a few short sentences, what you want, regarding CGM (continuous glucose monitoring) alarms! The FDA has mandated that CGM LOW BG alarms MAY NOT be turned off or...
Aug 10, 2022 | Advocacy, Featured
From one of the founders of the #WeAreNotWaiting” movement: “Hey FDA, if you had been listening to us, we wouldn’t have had to overwhelm you with public comments!” This is about the Fulfillment of 21st Century Cures Act Section 3060...
Jul 25, 2022 | Advocacy, Featured, Research News, Technology Updates
Experimental drug may help restore insulin-producing cells was written by Clarissa Brincat for MedicalNewsToday.com, 22 July 2022. In a recent study, the human epigenetics team at Monash University in Melbourne, Australia, found that the investigational drug GSK-126...
Jul 18, 2022 | Advocacy, Featured, Foods, Technology Updates
Diabetes Patients Flood FDA with Comments on Cybersecurity for Medical Devices, as reported by Mariam Baksh for NextGov.com, 8 July 2022. The Food and Drug Administration received more than a thousand comments—mainly from diabetes patients and their family...
Jul 11, 2022 | Advocacy, Featured, Foods, Technology Updates
Vertex, continuing its rebound, cleared to resume testing of diabetes cell therapy was written by Ben Fidler for BioPharmaDive.com, 6 July 2022. The Food and Drug Administration has cleared Vertex Pharmaceuticals to resume a study evaluating an...